However, ABC-transporters can mediate considerable MDR in vitro or in animal models, likely by decreasing the uptake or accumulation of chemotherapeutic agents in cancer cells (Szakács et al. 2006; Robey et al. 2018). The gene discussed is ABCG2; the disease is cancer.